Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

5 results about "Withania somnifera" patented technology

Withania somnifera, known commonly as ashwagandha, Indian ginseng, poison gooseberry, or winter cherry is a plant in the Solanaceae or nightshade family. Several other species in the genus Withania are morphologically similar. Although commonly used as a medicinal herb in Ayurvedic medicine, there is no conclusive clinical evidence that it is effective for treating any ailment.

Plant composition with whitening effect and application thereof

PendingCN122351106ABiotechnologySkin repair
This invention relates to a plant composition with whitening effects and its application. The whitening plant composition includes extracts of *Scleroderma wilfordii*, *Myrothamnus flabellifolia*, and *Solanum nigrum* root. The whitening plant composition of this invention utilizes the combination of three plant extracts, resulting in a rational formulation where each active ingredient complements the others, synergistically enhancing their effects. This effectively inhibits tyrosinase activity and reduces melanin synthesis, exhibiting significant whitening efficacy. When applied to cosmetics, this plant composition results in stable products that also provide skin repair, reduce the irritation of whitening ingredients, and are suitable for various skin types, fully meeting consumers' demand for natural, gentle, and highly effective whitening products.
Owner:GUANGZHOU LI YAN ZHUANG BIOLOGICAL TECH CO LTD

Composition of Withania somnifera to improve memory and cognition.

PendingBR112025019128A2CognitionBiochemistry
The present invention relates to a medicinal composition derived from withania somnifera extract comprising withanolides and sominone wherein said sominone in the extract is standardized in the range of 0.1-30%. Withanolides in the said composition are in the range of 10-60%. It is further comprising withanolide glycosides and withaferin A. Medicinal composition along with pharmaceutically acceptable excipients are formulated into a dosage form. It also discloses a method of preparation of said medicinal composition. Said composition is used to improve memory and cognition when administered to subjects in the appropriate dosage. Said composition is capable of enhancing the bioavailability of its constituents.
Owner:ARJUNA NATURAL PTE LTD

An herbal pre-mix formulation for beverage preparation and process of preparation thereof

PCT designated stageWO2026110206A1Nervous disorderFood scienceBiotechnologyCinnamomum verum
An herbal pre-mix formulation for beverage preparation and process of preparation thereof The present invention discloses an herbal pre-mix formulation for beverage preparation, the formulation comprising a primary herb selected from Himalayan Musk Root (Nardostachys jatamansi); and secondary herbs selected from Lemongrass (Cymbopogon citratus), Ashwagandha (Withania somnifera), Cinnamon (Cinnamomum verum), Spearmint (Mentha spicata), and Peppermint (Mentha piperita). The present invention also discloses a process for preparing the pre-mix formulation for beverage preparation.
Owner:MIZUGAMI MARKETING PTE LTD

Application of withania somnifera in combination with melatonin

PendingUS20260137748A1Organic active ingredientsNervous disorderPsychiatryWithania somnifera
The application relates to a combined use of Withania somnifera and Melatonin. In the application, after using Withania somnifera and Melatonin in combination, they have significantly synergistic effects in improving sleep and / or improving emotion. Especially, the effects of improving sleep and / or improving emotion achieved by the way of administrating Withania somnifera in the morning in combination with administrating Melatonin in the evening are better than the effects achieved by simultaneously administrating them in the evening and by administrating each of them alone.
Owner:NANJING HAIGUANG INSTITUTE OF APPLIED CHEMISTRY CO LTD

Composition, dosage form and associated dietary supplement for reducing the sleep onset phase and improving the sleep-wake rhythm

Composition including: a) Melatonin up to 5 mg; b) Magnesium up to 500 mg c) Withania somnifera up to 2 g; d) Gamma-aminobutyric acid up to 500 mg; e) L-tryptophan up to 1 g; f) L-Theanine up to 50 mg; g) 5-Hydroxytryptophan up to 100 mg; h) Matricaria chamomilla extract up to 500 mg; i) Valeriana officinalis extract up to 800 mg; and j) Vitamin B6 up to 5 mg.
Owner:EPIGENICS GMBH